Literature DB >> 27226406

The rising cost of hospital care for children with gastroparesis: 2004-2013.

P L Lu1, M Moore-Clingenpeel2, D Yacob3, C Di Lorenzo3, H M Mousa4.   

Abstract

BACKGROUND: The cost of hospital care for adults with gastroparesis (GP) is increasing. Our objective was to evaluate the cost of hospital care for children with GP.
METHODS: Using the Pediatric Health Information System, we selected hospitalizations with a diagnosis of GP (ICD-9 536.3), dyspepsia and other specified disorders of function of stomach (DYS, 536.8) and unspecified functional disorder of stomach (UFD, 536.9) from 2004 to 2013. We recorded dates of hospitalization, demographics, costs, and length of stay (LOS). KEY
RESULTS: From 2004 to 2013, 4015 patients were admitted for GP (54.2% female, median age 8 years). Total cost of hospitalization for GP increased 5.8 fold from $6 185 390 to $35 654 075 (p = 0.0001). Cost per hospitalization did not change. Cost of initial hospitalization was highest in patients 0-5 years and lowest in patients 16-21 years (p < 0.0001). Number of hospitalizations each year for GP increased from 252 to 1310 (p < 0.0001) and unique patients hospitalized increased from 174 to 723 (p < 0.0001). Number of hospitalizations and unique patients for DYS/UFD also increased (p < 0.0001). LOS for GP did not change with time. Females and younger GP patients had more repeat hospitalizations (p < 0.0001, p < 0.0001). CONCLUSIONS & INFERENCES: The financial burden of hospitalization for pediatric GP has increased dramatically from 2004 to 2013, driven by a rise in number of hospitalizations and unique patients hospitalized each year. Cost and LOS per hospitalization remain stable. Unlike in adults, hospitalizations for DYS/UFD have also increased, suggesting that the increase in hospitalizations for GP is not secondary to changing diagnostic practices.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  gastroparesis; hospitalization; pediatrics

Mesh:

Year:  2016        PMID: 27226406     DOI: 10.1111/nmo.12869

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  9 in total

Review 1.  Childhood gastroparesis is a unique entity in need of further investigation.

Authors:  Liz Febo-Rodriguez; Bruno P Chumpitazi; Robert J Shulman
Journal:  Neurogastroenterol Motil       Date:  2019-08-13       Impact factor: 3.598

Review 2.  Pediatric enteric neuropathies: diagnosis and current management.

Authors:  Maggie L Westfal; Allan M Goldstein
Journal:  Curr Opin Pediatr       Date:  2017-06       Impact factor: 2.856

3.  Hypoganglionosis in the gastric antrum causes delayed gastric emptying.

Authors:  Corey Baker; Minhal Ahmed; Katarina Cheng; Emily Arciero; Sukhada Bhave; Wing Lam N Ho; Allan M Goldstein; Ryo Hotta
Journal:  Neurogastroenterol Motil       Date:  2019-11-26       Impact factor: 3.598

4.  Aripiprazole reversed gastroparesis in a child with 1q21.1-q21.2 microdeletion.

Authors:  Simon S Rabinowitz; Neha Ahuja; Jennifer Gottfried
Journal:  BMJ Case Rep       Date:  2018-03-15

5.  Barriers in Neurogastroenterology and Motility Training Experience for Pediatric Gastroenterology Fellows.

Authors:  Kahleb Graham; Jaime Belkind-Gerson; Anil Darbari; John T Boyle
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-06       Impact factor: 2.839

Review 6.  Parkinson's Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects.

Authors:  Chethan Ramprasad; Jane Yellowlees Douglas; Baharak Moshiree
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

7.  Clinical Characterization of Pediatric Gastroparesis Using a Four-hour Gastric Emptying Scintigraphy Standard.

Authors:  Sharon Wolfson; Zoe Wilhelm; Antone R Opekun; Robert Orth; Robert J Shulman; Bruno P Chumpitazi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-06-01       Impact factor: 3.288

8.  Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children.

Authors:  Suzanna Hirsch; Samuel Nurko; Paul Mitchell; Rachel Rosen
Journal:  Paediatr Drugs       Date:  2021-12-23       Impact factor: 3.930

Review 9.  Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management.

Authors:  Dhiren Patel; Albert Shan; Stacy Mathews; Meghana Sathe
Journal:  Nutrients       Date:  2022-02-28       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.